441 related articles for article (PubMed ID: 20873400)
21. Topical iontophoretic administration of acyclovir for the episodic treatment of herpes labialis: a randomized, double-blind, placebo-controlled, clinic-initiated trial.
Morrel EM; Spruance SL; Goldberg DI;
Clin Infect Dis; 2006 Aug; 43(4):460-7. PubMed ID: 16838235
[TBL] [Abstract][Full Text] [Related]
22. Penciclovir cream--improved topical treatment for herpes simplex infections.
Schmid-Wendtner MH; Korting HC
Skin Pharmacol Physiol; 2004; 17(5):214-8. PubMed ID: 15452407
[TBL] [Abstract][Full Text] [Related]
23. [Recurrent herpes simplex labialis infections. Possible prevention with a new therapeutic regimen].
Harmenberg J; Spruance S
Lakartidningen; 2010 Aug 25-31; 107(34):1918-22. PubMed ID: 20960953
[No Abstract] [Full Text] [Related]
24. Prevention of ulcerative lesions by episodic treatment of recurrent herpes labialis: A literature review.
Harmenberg J; Oberg B; Spruance S
Acta Derm Venereol; 2010 Mar; 90(2):122-30. PubMed ID: 20169294
[TBL] [Abstract][Full Text] [Related]
25. Treatment of herpes labialis.
Fiddian AP; Yeo JM; Clark AE
J Infect; 1983 May; 6(1 Suppl):41-7. PubMed ID: 6350474
[TBL] [Abstract][Full Text] [Related]
26. Successful treatment of herpes labialis with topical acyclovir.
Fiddian AP; Yeo JM; Stubbings R; Dean D
Br Med J (Clin Res Ed); 1983 May; 286(6379):1699-701. PubMed ID: 6405939
[TBL] [Abstract][Full Text] [Related]
27. Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir.
Tyring SK; Baker D; Snowden W
J Infect Dis; 2002 Oct; 186 Suppl 1():S40-6. PubMed ID: 12353186
[TBL] [Abstract][Full Text] [Related]
28. Current management and recommendations for access to antiviral therapy of herpes labialis.
Cunningham A; Griffiths P; Leone P; Mindel A; Patel R; Stanberry L; Whitley R
J Clin Virol; 2012 Jan; 53(1):6-11. PubMed ID: 21889905
[TBL] [Abstract][Full Text] [Related]
29. Failure of acyclovir cream in treatment of recurrent herpes labialis.
Shaw M; King M; Best JM; Banatvala JE; Gibson JR; Klaber MR
Br Med J (Clin Res Ed); 1985 Jul; 291(6487):7-9. PubMed ID: 3926067
[TBL] [Abstract][Full Text] [Related]
30. Acyclovir in the management of herpes labialis.
Yeo JM; Fiddian AP
J Antimicrob Chemother; 1983 Sep; 12 Suppl B():95-103. PubMed ID: 6355056
[TBL] [Abstract][Full Text] [Related]
31. Penciclovir cream for the treatment of sunlight-induced herpes simplex labialis: a randomized, double-blind, placebo-controlled trial. Penciclovir Cream Herpes Labialis Study Group.
Boon R; Goodman JJ; Martinez J; Marks GL; Gamble M; Welch C
Clin Ther; 2000 Jan; 22(1):76-90. PubMed ID: 10688392
[TBL] [Abstract][Full Text] [Related]
32. A clinical evaluation of a novel liposomal carrier for acyclovir in the topical treatment of recurrent herpes labialis.
Horwitz E; Pisanty S; Czerninski R; Helser M; Eliav E; Touitou E
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1999 Jun; 87(6):700-5. PubMed ID: 10397661
[TBL] [Abstract][Full Text] [Related]
33. Herpes labialis.
Worrall G
Clin Evid; 2002 Jun; (7):1513-8. PubMed ID: 12230767
[No Abstract] [Full Text] [Related]
34. Acyclovir cream for treatment of herpes simplex labialis: results of two randomized, double-blind, vehicle-controlled, multicenter clinical trials.
Spruance SL; Nett R; Marbury T; Wolff R; Johnson J; Spaulding T
Antimicrob Agents Chemother; 2002 Jul; 46(7):2238-43. PubMed ID: 12069980
[TBL] [Abstract][Full Text] [Related]
35. Docosanol: new drug. Herpes labialis: barely more effective than an excipient.
Prescrire Int; 2009 Jun; 18(101):106-7. PubMed ID: 19637417
[TBL] [Abstract][Full Text] [Related]
36. A comparison of topical application of penciclovir 1% cream with acyclovir 3% cream for treatment of genital herpes: a randomized, double-blind, multicentre trial.
Chen XS; Han GZ; Guo ZP; Lu NZ; Chen J; Wang JB;
Int J STD AIDS; 2000 Sep; 11(9):568-73. PubMed ID: 10997497
[TBL] [Abstract][Full Text] [Related]
37. Prophylactic chemotherapy with acyclovir for recurrent herpes simplex labialis.
Spruance SL
J Med Virol; 1993; Suppl 1():27-32. PubMed ID: 8245889
[TBL] [Abstract][Full Text] [Related]
38. An update on short-course intermittent and prevention therapies for herpes labialis.
Gilbert S; Corey L; Cunningham A; Malkin JE; Stanberry L; Whitley R; Spruance S
Herpes; 2007 Jun; 14 Suppl 1():13A-18A. PubMed ID: 17877887
[TBL] [Abstract][Full Text] [Related]
39. Protocol for a randomised controlled trial of 90% kanuka honey versus 5% aciclovir for the treatment of herpes simplex labialis in the community setting.
Semprini A; Singer J; Shortt N; Braithwaite I; Beasley R;
BMJ Open; 2017 Aug; 7(8):e017766. PubMed ID: 28775197
[TBL] [Abstract][Full Text] [Related]
40. Topical acyclovir therapy in patients with recurrent orofacial herpes simplex infections.
Van Vloten WA; Swart RN; Pot F
J Antimicrob Chemother; 1983 Sep; 12 Suppl B():89-93. PubMed ID: 6355055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
